home / stock / seer / seer news


SEER News and Press, Seer Inc. From 03/30/21

Stock Information

Company Name: Seer Inc.
Stock Symbol: SEER
Market: NASDAQ
Website: seer.bio

Menu

SEER SEER Quote SEER Short SEER News SEER Articles SEER Message Board
Get SEER Alerts

News, Short Squeeze, Breakout and More Instantly...

SEER - Seer, Inc. (SEER) Q4 2020 Earnings Call Transcript

Image source: The Motley Fool. Seer, Inc. (NASDAQ: SEER) Q4 2020 Earnings Call Mar 29, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Seer, Inc. (SEER) Q4 2020 Earnings Call Transcript

SEER - Seer signs agreement with SCIEX to offer Proteomics Solutions

Seer (SEER) signs a non-exclusive commercial deal with SCIEX, a global leader in life science analytical technologies.This deal will allow Seer to market SCIEX mass spectrometry systems concurrently with its Proteograph Product Suite.Previously (March 29): Seer EPS misses by $0.41, beats on r...

SEER - Seer's (SEER) CEO Omid Farokhzad on Q4 and Full Year 2020 Results - Earnings Call Transcript

Seer, Inc. (SEER) Q4 and Full Year 2020 Earnings Conference Call March 29, 2021 4:30 PM ET Company Participants Carrie Mendivil – Investor Relations Omid Farokhzad – Chairman, Chief Executive Officer and Founder Omead Ostadan – President and Chief Operating Officer David ...

SEER - Seer EPS misses by $0.41, beats on revenue

Seer (SEER): Q4 GAAP EPS of -$0.54 misses by $0.41.Revenue of $0.34M beats by $0.24M.Net loss was $12.9M vs. net loss of $5.1M for the corresponding prior year period.Cash, cash equivalents and investments were $431.9M as of December 31, 2020Press Release For further details see: S...

SEER - Seer and SCIEX Sign Commercial Agreement to Offer End-to-End Unbiased Proteomics Solutions

REDWOOD CITY, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Seer (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, announced today that they have signed a non-exclusive commercial agreement with SCIEX, a global leader in life science analytical t...

SEER - Seer Reports Fourth Quarter and Full Year 2020 Financial Results and Fuels Commercial Progress in 2021 with New Collaborators and Partnerships

REDWOOD CITY, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the quarter and full year ended December 31, 2020. “I am extremely pro...

SEER - Notable earnings after Monday's close

[[SEER]]For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Monday's close

SEER - Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2020 Update

Halvorsen's 13F portfolio value increased from $27.68B to $36.37B. The number of positions increased from 86 to 96. Viking Global added UnitedHealth, AbCellera Biologics, Walt Disney, and Palo Alto Networks while dropping Analog Devices, CME Group, Comcast, and Exact Sciences. The...

SEER - Olink Holding Pursues $300 Million U.S. IPO Effort

Olink Holding AB has filed to raise $300 million in a U.S. IPO. The firm provides proteomics equipment and technologies to academic and biopharmaceutical research organizations worldwide. OLK has grown revenue only moderately while the IPO appears excessively priced, so I'll watch...

SEER - Seer to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021

REDWOOD CITY, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the fourth quarter and full year 2020 after market close on Monday, Mar...

Previous 10 Next 10